SCHEMBL29566758

SCHEMBL29566758

Cc1ccccc1Oc1nc(NS(=O)(=O)c2cnn(C)c2)nc(-c2ccccc2C)c1OC(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 9/20 0.40
▸ HTR7 P34969 9/20 0.40
▸ DRD2 P14416 4/20 0.38
▸ HTR6 P50406 1/20 0.38
▸ THRB P10828 1/20 0.33
▸ HTR2A P28223 3/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ EGFR P00533 1/20 0.32
▸ FGFR1 P11362 1/20 0.32
▸ KDR P35968 1/20 0.32
▸ PIK3CD O00329 1/20 0.32
▸ PIK3CB P42338 1/20 0.32
▸ MTOR P42345 1/20 0.32
▸ PIK3CG P48736 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.32
▸ SCN9A Q15858 1/20 0.32
▸ ALK Q9UM73 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310674 1.00 HTR1A (0.40) HTR1AHTR7DRD2HTR6THRB
SCHEMBL24309396 0.90 HTR1A (0.42) HTR1AHTR7DRD2HTR6THRB
SCHEMBL29567189 0.90 HTR1A (0.42) HTR1AHTR7DRD2HTR6THRB
SCHEMBL24309376 0.88 HTR1A (0.41) HTR1AHTR7DRD2HTR6THRB
SCHEMBL29566724 0.88 HTR1A (0.41) HTR1AHTR7DRD2HTR6THRB
SCHEMBL24309794 0.88 HTR1A (0.38) HTR1AHTR7DRD2HTR6EGFR
SCHEMBL29566900 0.88 HTR1A (0.43) HTR1AHTR7DRD2HTR6THRB
SCHEMBL24309827 0.88 HTR1A (0.43) HTR1AHTR7DRD2HTR6THRB
SCHEMBL24309825 0.86 HTR1A (0.42) HTR1AHTR7DRD2HTR6THRB
SCHEMBL24310178 0.86 HTR1A (0.42) HTR1AHTR7DRD2HTR6THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback